Difficulty: Medium
Average Score: 70%
Practice
Which drug is associated with increased lipoprotein levels?
Correct answer
B
Rationale
In the context of client-centered care principles, it is vital for healthcare professionals to have a deep understanding of the pharmacological effects of different drugs to ensure safe and effective patient care. In this case, the correct answer is B) Hydrochlorothiazide (Microzide), as it is associated with increased lipoprotein levels, particularly LDL cholesterol, as a side effect.
Hydrochlorothiazide is a thiazide diuretic commonly prescribed to manage hypertension and edema. One of its known side effects is altering lipid levels in the body, leading to an increase in LDL cholesterol and triglycerides. This effect can be detrimental to patients, especially those with existing cardiovascular risk factors.
Option A, Furosemide (Lasix), is a loop diuretic that is not typically associated with significant changes in lipoprotein levels. While it may cause electrolyte imbalances, it is not a primary concern for lipid management.
Option C, Spironolactone (Aldactone), is a potassium-sparing diuretic that is more commonly known for its potential to increase potassium levels. It is not directly linked to alterations in lipoprotein levels.
Option D, Triamterene (Dyrenium), is another potassium-sparing diuretic that does not have a significant impact on lipoprotein levels. Its primary concern is hyperkalemia rather than lipid abnormalities.
Understanding the potential side effects of different medications is crucial in providing patient-centered care. Healthcare providers must consider these effects when selecting appropriate treatments for individual patients, taking into account their unique medical history and risk factors. By knowing the specific effects of each drug, healthcare professionals can make informed decisions to optimize patient outcomes and minimize adverse effects.
Hydrochlorothiazide is a thiazide diuretic commonly prescribed to manage hypertension and edema. One of its known side effects is altering lipid levels in the body, leading to an increase in LDL cholesterol and triglycerides. This effect can be detrimental to patients, especially those with existing cardiovascular risk factors.
Option A, Furosemide (Lasix), is a loop diuretic that is not typically associated with significant changes in lipoprotein levels. While it may cause electrolyte imbalances, it is not a primary concern for lipid management.
Option C, Spironolactone (Aldactone), is a potassium-sparing diuretic that is more commonly known for its potential to increase potassium levels. It is not directly linked to alterations in lipoprotein levels.
Option D, Triamterene (Dyrenium), is another potassium-sparing diuretic that does not have a significant impact on lipoprotein levels. Its primary concern is hyperkalemia rather than lipid abnormalities.
Understanding the potential side effects of different medications is crucial in providing patient-centered care. Healthcare providers must consider these effects when selecting appropriate treatments for individual patients, taking into account their unique medical history and risk factors. By knowing the specific effects of each drug, healthcare professionals can make informed decisions to optimize patient outcomes and minimize adverse effects.